BELLEVUE ASSET MANAGEMENT, LLC - DECIPHERA PHARMACEUTICALS IN ownership

DECIPHERA PHARMACEUTICALS IN's ticker is DCPH and the CUSIP is 24344T101. A total of 189 filers reported holding DECIPHERA PHARMACEUTICALS IN in Q4 2020. The put-call ratio across all filers is 0.96 and the average weighting 0.3%.

Quarter-by-quarter ownership
BELLEVUE ASSET MANAGEMENT, LLC ownership history of DECIPHERA PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2021$2,0000.0%490.0%0.00%0.0%
Q2 2021$2,000
-33.3%
49
-12.5%
0.00%
-50.0%
Q1 2021$3,0000.0%56
-3.4%
0.00%0.0%
Q4 2020$3,0000.0%58
-13.4%
0.00%0.0%
Q3 2020$3,000
-25.0%
670.0%0.00%
-50.0%
Q2 2020$4,000
+33.3%
670.0%0.00%
+33.3%
Q1 2020$3,000
+50.0%
67
+148.1%
0.00%
+50.0%
Q4 2019$2,000270.00%
Other shareholders
DECIPHERA PHARMACEUTICALS IN shareholders Q4 2020
NameSharesValueWeighting ↓
New Leaf Venture Partners, L.L.C. 1,209,571$11,213,0005.53%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 5,580,456$51,731,0001.16%
ARMISTICE CAPITAL, LLC 5,836,000$54,100,0001.05%
Pinz Capital Management, LP 165,835$1,537,0000.96%
Sunesis Advisors, LLC 96,299$893,0000.52%
Redmile Group, LLC 664,817$6,163,0000.19%
PDT Partners, LLC 222,343$2,061,0000.18%
Bayesian Capital Management, LP 41,900$388,0000.06%
Laurion Capital Management LP 459,290$4,258,0000.05%
Hennion & Walsh Asset Management, Inc. 101,643$942,0000.05%
View complete list of DECIPHERA PHARMACEUTICALS IN shareholders